Categories
- PROTAC Linker
- Protein Control Ligand
- Pathway Inhibitors
- Function Modulators
- Activators
- G Protein-Coupled Receptor Ligands
- Nuclear Receptor Ligands
- GDNF Receptors
- TNF Receptors
- Transcription Factors
- Chemokines
- Cytokine Receptors
- Biomarkers and Buffer Solutions
- Molecular Probes
- Stem Cell Research
- Alzheimer's Disease
- Apoptosis
- Cancer Research
- Epigenetics
- Metabolites
- PET/SPECT Imaging Precursors
- Customized Screening Library
- Ultra Pure Pharmacological Standard
- Tissue Microarray (TMA)
- Proteins and Antibodies
- Primary Cells
- ELISA KIT
- Natural Products
- Lab Equipments
- Humanized Mice for PDX Platform
- Rare Chemicals
- Custom Synthesis
- Antibacterial
- Antifungal
- Antioxidant
- Antiviral
- Molecular Glues
- SARS-CoV
Quantity Discount Table - Order More To Get More Price Discount
| Quantity | mg | Unit Price ($/mg or $/Unit) | Final Price |
|---|---|---|---|
| 1 | 5 | $186.15 | Total: $930.75 |
| 1 | 10 | $157.68 | Total: $1,576.80 |
| 1 | 25 | $133.59 | Total: $3,339.75 |
| 1 | 50 | $113.88 | Total: $5,694.00 |
| 1 | 100 | $98.55 | Total: $9,855.00 |
Overview
GAT107 is a novel and potent ?7 nicotinic cholinergic receptor modifier agonist and modulator with anti-inflammatory activity that reverses injury perception in a mouse model of neuropathic pain.
Chemical Properties
| Molecular Formula | C18H17BrN2O2S |
| Molecular Weight | 405.31 |
| CAS Numbers | 1476807-74-5 |
| Solubility | DMSO |
| Purity | 98% by HPLC |
| SMILES Code | S(N)(=O)(=O)C=1C=C2[C@@]3([C@]([C@H](NC2=CC1)C4=CC=C(Br)C=C4)(CC=C3)[H])[H] |
Storage and Handling
0C Short Term, -20C Long Term
References
Gauthier AG, et al. GAT107-mediated ?7 nicotinic acetylcholine receptor signaling attenuates inflammatory lung injury and mortality in a mouse model of ventilator-associated pneumonia by alleviating macrophage mitochondrial oxidative stress via reducing MnSOD-S-glutathionylation. Redox Biol. 2023 Apr;60 102614.